Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue

Journal of Neuro-Oncology

Volumn 44, Issue 1, 1999, Pages 71-76

  Tada, Tsuyoshi ^a   Takizawa, Takeomi ^a   Nakazato, Fumi ^a   Kobayashi, Shigeaki ^a   Koike, Kenichi ^a   Oguchi, Masahiko ^a   Ishii, Eizaburo ^b   Amano, Yoshiro ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGANO CHILDREN'S HOSPITAL   (Japan)

^c Suwa Red Cross Hospital   (Japan)

Author keywords

ACNU; Autologous stem cell transplantation; Brain neoplasms; Cisplatin; Etoposide; Malignant germ cell tumors

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; NIMUSTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW SUPPRESSION; BRAIN TUMOR; CANCER SURVIVAL; CHORIOCARCINOMA; CLINICAL ARTICLE; DRUG MEGADOSE; EMBRYONAL CARCINOMA; FEMALE; FEVER; GERM CELL TUMOR; HEARING DISORDER; HUMAN; LIVER DYSFUNCTION; MALE; NEPHROTOXICITY; NEUTROPHIL; PRESCHOOL CHILD; STEM CELL TRANSPLANTATION; YOLK SAC TUMOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GERMINOMA; HEMATOLOGIC TESTS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0032743207     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006395719917     Document Type: Article

References (22)

1. Hoffman HJ, Otsubo H, Hendrick EB, Humphreys RP, Drake JM, Becker LE, Greenberg M, Jenkin D: Intracranial germ-cell tumors in children. J Neurosurg 74: 545-551, 1991
2. Nomura K: Special report of brain tumor registry of Japan (1969-1990). Part II Results of treatment. Neuro Med Chir 39: 76-106, 1999
3. Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13: 70-82, 1986
4. Sebag-Montefiore DJ, Douek E, Kingston JE, Plowman PN: Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy. Clin Oncol 4: 345-350, 1992
5. Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, Kun LE: Preirradiation, cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol 8: 330-336, 1990
6. Hainsworth JD, Williams SD, Einhorn LH, Birch R, Greco FA: Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern cancer study group trial. J Clin Oncol 3: 666-671, 1985
7. Kobayashi T, Yoshida J, Ishiyama J, Noda S, Kito A, Kida Y: Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study. J Neurosurg 70: 676-681, 1989
8. Yoshida J, Sugita K, Kobayashi T, Takakura K, Shitara N, Matsutani M, Tanaka R, Nagai H, Yamada H, Yamashita J, Oda Y, Hayakawa T, Ushio Y: Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir 120: 111-117, 1993
9. Robertson PL, DaRosso RC, Allen JC: Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J Neurooncol 32: 71-80, 1997
10. Ushio Y, Kochi M, Kuratsu J, Itoyama Y, Marubashi T: Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg 90: 133-137, 1999
11. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T: Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86: 446-455, 1997
12. Horowitz MM, Rowlings PA: An update from the international bone marrow transplant registry and the autologous blood and marrow transplant registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 4: 395-400, 1997
13. Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli M, Rubagotti A, Congiu A, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli L, Sileni V, Miggiano M, Marino G, Damasio E, Rizzoli V: VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group. J Clin Oncol 16: 2796-2802, 1998
14. Droz JP, Pico JL, Kramar A: Role of autologous bone marrow transplantation in germ-cell cancer. Urol Clin North Am 20: 161-171, 1993
15. Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC: A randomized trial of standard chemotherapy vs a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J Clin Oncol 6: 1031-1040, 1988
16. Postmus PE, Mulder NH, Sleijfer DT, Meinesz AF, Vriesendorp R, de Vries EG: High-dose etoposide for refractory malignancies: a phase I study. Cancer Treat Rep 68: 1471-1474, 1984
17. Postmus PE, Holthuis JJM, Haaxma-Reiche H, Mulder NH, Vencken LM, van Oort WJ, Sleijfer DT, Sluiter HJ: Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 2: 215-220, 1984
18. Ikuta K, Fujioka K, Sumita H, Takahashi H, Sekiguchi H, Kai S, Kajigaya Y, Funabiki T, Sakai H, Matsuyama S: High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia. Rinsho Ketsueki 34: 636-642, 1993
19. Ishii H, Osa Y, Okano T, Isaka S, Yasuda K, Shimazaki J: High dose chemotherapy and autologous bone marrow transplantation for advanced germ cell tumor. Nippon Hinyokika Gakkai Zasshi 81: 1473-1479, 1990
20. Ohnuma N, Takahashi H, Kaneko M, Uchino J, Takeda T, Iwafuchi M, Ohhira M, Nishihira H, Mugishima H, Yokoyama J, Okada A, Nagahara N, Taguchi N, Tsuchida Y: Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the study group of Japan. Med Pediatr Oncol 24: 181-187, 1995
21. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich J, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Ill EF, Antman KH: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79: 3036-3044, 1992
22. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1: 329-341, 1992